Investment Manager
Jackson

JNL/Mellon Healthcare Sector A

As of 11/30/25

Operations

Expense Ratio (04/28/25) 0.63% of fund assets
Inception Date 07/02/99
Advisor Jackson National Asset Management LLC
Subadvisor Mellon Investments Corporation

Prospectus Benchmarks**

Primary Morningstar US Market Ext TR USD
Secondary Morningstar US Health TR USD

Portfolio Managers

David France 2020; Marlene Walker-Smith 2020; Michael Stoll 2020; Todd Frysinger 2020; Vlasta Sheremeta 2020

These portfolios are only available as sub-accounts within variable annuity products. Variable annuities are long-term, tax-deferred investments designed for retirement, involve investment risks and may lose value. Earnings are taxable as ordinary income when distributed. Individuals may be subject to a 10% additional tax for withdrawals before age 59½ unless an exception to the tax is met.

Portfolio Composition 09/30/25

Asset Allocation

138
3%
$2,848.19
Assets
Eli Lilly and Co 10.73%
Johnson & Johnson 7.86%
AbbVie Inc 7.19%
UnitedHealth Group Inc 5.51%
Abbott Laboratories 4.10%
Merck & Co Inc 3.63%
Thermo Fisher Scientific Inc 3.23%
Intuitive Surgical Inc 2.81%
Amgen Inc 2.67%
Pfizer Inc 2.54%
Assets
United States 99.80%
United Kingdom 0.10%
Switzerland 0.10%
Morningstar Category
Health
Overall Morningstar RatingTM
Star Rating
Morningstar Return
Above Average
Morningstar Risk
Below Average
Out of 164 Health funds. An investment’s overall Morningstar Rating, based on its risk-adjusted return, is a weighted average of its applicable 3-, 5-, and 10-year Ratings. See important disclosures for details.

Morningstar Proprietary Statistics 11/30/25

1 Year 3 Year 5 Year 10 Year
Morningstar Rating -- 3yr Rating 5yr Rating 10yr Rating
Out of # of Investments -- 164 152 118
VA - Underlying Fund Peer Group
Fund Rank Percentile 68 73 27 28
Out of # of Investments 172 164 152 118

Investment Strategyfrom the prospectus

The investment seeks to track the performance of the Morningstar ® US Healthcare Index SM to provide total return through capital appreciation and dividend income. The fund invests under normal circumstances at least 80% of its assets (net assets plus the amount of any borrowings made for investment purposes) in the securities in the index in proportion to their market capitalization weighting in the index. The index measures the performance of companies of biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term care facilities, and medical equipment and supplies. The fund is non-diversified.

Portfolio Analysis

Morningstar Ownership ZoneTM 09/30/25 More Information...

Morningstar Ownership Zone
Giant Large Medium Small Micro
Deep
Value
Core
Value
Blend
Core
Growth
High
Growth

3 Year Risk Measures 11/30/25

Standard Deviation* Sharpe Ratio*
Sub-account 13.55 0.12
Morningstar Category 17.83 0.23
Modern Portfolio Theory Statistics
Relative to: Alpha* Beta* R-Squared*
Primary Prospectus Benchmark** (Morningstar US Market Ext TR USD) -5.90 0.53 26.53
Morningstar Category**
(Morningstar US Health TR USD)
-0.63 1.00 100.00

Morningstar Style BoxTM 09/30/25 More Information...

Morningstar Equity Style Box
Market Cap
Giant 10.73%
Large 59.37%
Medium 21.79%
Small 7.25%
Micro 0.44%

Top Sectors 11/30/25 09/30/25

Sub-acct Bmark
Cyclical icon Cyclical 0.00% 27.79%
Basic Materials icon Basic Materials 0.00% 1.82%
Consumer Cyclical icon Consumer Cyclical 0.00% 10.66%
Financial Services icon Financial Services 0.00% 12.99%
Real Estate icon Real Estate 0.00% 2.32%
Sensitive icon Sensitive 0.00% 55.10%
Communication Services icon Communication Services 0.00% 10.34%
Energy icon Energy 0.00% 2.93%
Industrials icon Industrials 0.00% 8.51%
Technology icon Technology 0.00% 33.32%
Defensive icon Defensive 100.00% 17.12%
Consumer Defensive icon Consumer Defensive 0.00% 4.61%
Healthcare icon Healthcare 100.00% 10.19%
Utilities Utilities 0.00% 2.32%

Perspective II Sub-account Performance11/30/25

Contract Disclosure
Marketing Name Perspective II Variable and Fixed Annuity
Contract Form Number VA775NY, VA775NY-CB1
Current Contract Offering Date June 24, 2019
Prospectus Link www.jackson.com/pdf/legal/jmv21451ny.pdf
Underlying Separate Account with Establishment Date JNL/NY Separate Account I; September 12, 1997
Annual Contract Maintenance Charge $30 - Waived for contract values over $50,000 on the contract anniversary.
Core Contract Charge 1.40%, 1.25% for contract values over $1,000,000 as assessed on the contract quarterly anniversary.
Monthly Contract Charge N/A
Withdrawal Charge Schedule 7.0% - 1st year, 6.0% - 2nd year, 5.0% - 3rd year, 4.0% - 4th year, 3.0% - 5th year, 2.0% - 6th year, 1.0% - 7th year, 0% thereafter
Minimum Initial Premium $10,000 (Non-Qualified), $5,000 (Qualified); In certain states, we reserve the right to refuse any subsequent premium payments.
Death Benefit Includes a standard return of premium death benefit and the option to elect an add-on death benefit for an additional fee. Death benefits terminate if contract value falls to zero. Additionally add-on death benefits terminate upon spousal continuation.

Standardized average annual total returns are calculated based on a $10,000 hypothetical investment and reflect the deduction of the applicable withdrawal charge, core contract charge or mortality, expense, and administration charge, whichever is applicable, fund expenses, and annual contract maintenance charge or monthly contract charge, whichever is applicable (based as a percentage of average contract size). Non-Standardized returns with withdrawal charges reflect the deduction of the applicable withdrawal charge, core contract charge or mortality and expense risk and administration charge, whichever is applicable, and fund expenses. Non-standardized returns reflect the deduction of the core contract charge or mortality, expense, and administration charge, whichever is applicable, and fund expenses. Please refer to the contract disclosure table for the applicable charges. The costs of add-on benefits are not included in any of these performance results. Selection of an add-on benefit, if available, would reduce the returns shown.

Past performance does not guarantee future results. Performance data shown represents past performance. Current performance may be lower or higher than the performance quoted. If viewing a printed version of this material, the most recent month-end performance may be found at www.jackson.com. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost.

Growth of 10k11/30/15 to 11/28/25(Non-Standardized) More Information...

Calendar Year Returns(Non-Standardized)

All indices referenced herein are unmanaged and not available for direct investment.

Total Returns

-------------------------- Annualized --------------------------
Report Type YTD 1 Year 3 Year 5 Year 10 Year Inclusion/
Inception
Non-Standardized
11/30/25
15.16% 7.76% 4.29% 5.86% 7.84% 6.82%
07/02/99
Non-Standardized
with withdrawals
11/30/25
8.86% 1.46% 2.89% 5.42% 7.84% 6.82%
07/02/99
Quarterly Standardized
09/30/25
-4.36% -14.87% 3.17% 3.92% 7.26% 7.54%
12/15/03
Monthly Standardized
11/30/25
8.85% 1.45% 2.88% 5.41% 7.83% 8.08%
12/15/03